Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy

被引:186
作者
Kemi, Ole Johan [1 ,2 ]
Ceci, Marcello [3 ,4 ]
Wisloff, Ulrik [2 ,5 ]
Grimaldi, Serena [3 ,4 ]
Gallo, Paolo [3 ,4 ]
Smith, Godfrey L. [1 ]
Condorelli, Gianluigi [3 ,4 ,6 ]
Ellingsen, Oyvind [2 ,5 ]
机构
[1] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
[2] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway
[3] Ist Ricovero & Cura Carattere Sci Multimed, Milan, Italy
[4] Fdn Parco Sci San Raffaele, Rome, Italy
[5] St Olavs Hosp, Dept Cardiol, Trondheim, Norway
[6] Univ Calif San Diego, Div Cardiol, Dept Med, La Jolla, CA 92093 USA
关键词
D O I
10.1002/jcp.21197
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cardiomyocyte hypertrophy differs according to the stress exerted on the myocardium. While pressure overload-induced cardiomyocyte hypertrophy is associated with depressed contractile function, physiological hypertrophy after exercise training associates with preserved or increased inotropy. We determined the activation state of myocardial Akt signaling with downstream substrates and fetal gene reactivation in exercise-induced physiological and pressure overload-induced pathological hypertrophies. C57BL/6J mice were either treadmill trained for 6 weeks, 5 days/week, at 85-90% of maximal oxygen uptake (VO2max), or underwent transverse aortic constriction (TAC) for 1 or 8 weeks. Total and phosphorylated protein levels were determined with SDS-PAGE, and fetal genes by real-time RT-PCR. In the physiologically hypertrophied heart after exercise training, total Akt protein level was unchanged, but Akt was chronically hyperphosphorylated at serine 473. This was accompanied by activation of the mammalian target of rapamycin (mTOR), measured as phosphorylation of its two substrates: the ribosomal protein S6 kinase-I (S6KI) and the eukaryotic translation initiation factor-4E binding protein-I (4E-BPI). Exercise training did not reactivate the fetal gene program (beta-myosin heavy chain, atrial natriuretic factor, skeletal muscle actin). In contrast, pressure overload after TAC reactivated fetal genes already after I week, and partially inactivated the Akt/mTOR pathway and downstream substrates after 8 weeks. In conclusion, changes in opposite directions of the myocardial Akt/mTOR signal pathway appears to distinguish between physiological and pathological hypertrophies; exercise training associating with activation and pressure overload associating with inactivation of the Akt/mTOR pathway.
引用
收藏
页码:316 / 321
页数:6
相关论文
共 50 条
[21]   Fibronectin Contributes to Pathological Cardiac Hypertrophy but not Physiological Growth [J].
Konstandin, Mathias H. ;
Voelkers, Mirko ;
Quijada, Pearl ;
De La Torre, Andrea ;
Din, Shabana ;
Gude, Natalie ;
Toko, Haruhiro ;
Sussman, Mark .
CIRCULATION, 2013, 128 (22)
[22]   Fibronectin contributes to pathological cardiac hypertrophy but not physiological growth [J].
Mathias H. Konstandin ;
Mirko Völkers ;
Brett Collins ;
Pearl Quijada ;
Mercedes Quintana ;
Andrea De La Torre ;
Lucy Ormachea ;
Shabana Din ;
Natalie Gude ;
Haruhiro Toko ;
Mark A. Sussman .
Basic Research in Cardiology, 2013, 108
[23]   Differential gene expression in pathological and physiological cardiac hypertrophy [J].
Crampton, M ;
Harrison, G ;
Murrell, W ;
Crane, D .
FASEB JOURNAL, 2004, 18 (08) :C89-C89
[24]   Fibronectin contributes to pathological cardiac hypertrophy but not physiological growth [J].
Konstandin, Mathias H. ;
Voelkers, Mirko ;
Collins, Brett ;
Quijada, Pearl ;
Quintana, Mercedes ;
De La Torre, Andrea ;
Ormachea, Lucy ;
Din, Shabana ;
Gude, Natalie ;
Toko, Haruhiro ;
Sussman, Mark A. .
BASIC RESEARCH IN CARDIOLOGY, 2013, 108 (05)
[25]   Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation [J].
Zhou, Yue ;
He, Xin ;
Chen, Yili ;
Huang, Yiyi ;
Wu, Lingling ;
He, Jiangui .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 468 (1-2) :394-399
[26]   Control of macrophage metabolism and activation by mTOR and Akt signaling [J].
Covarrubias, Anthony J. ;
Aksoylar, H. Ibrahim ;
Horng, Tiffany .
SEMINARS IN IMMUNOLOGY, 2015, 27 (04) :286-296
[27]   Micrornas Have Differential Degree of Expression in Pathological Cardiac Hypertrophy Compared to Physiological Cardiac Hypertrophy [J].
Martinelli, Nidiane C. ;
Cohen, Carolina ;
Silvello, Daiane ;
Biolo, Andreia ;
Andrades, Michael ;
dos Santos, Ktia ;
Clausell, Nadine ;
Rohde, Luis E. ;
Matte, Ursula .
CIRCULATION RESEARCH, 2015, 117
[28]   miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy [J].
Shi, Jia-yu ;
Chen, Chu ;
Xu, Xuan ;
Lu, Qi .
ACTA PHYSIOLOGICA, 2019, 227 (02)
[29]   Lysophospholipid and AKT signaling pathways in cardiac hypertrophy and protection [J].
Brown, JH ;
Xiao, CY ;
Del Re, D ;
Means, C ;
Miyamoto, S .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (01) :312-312
[30]   An investigation of hypertrophy-related genes in physiological and pathological models of cardiac hypertrophy [J].
Ferreira, L ;
Harrison, G ;
Headrick, JP .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 39 (03) :575-575